7OPM
Phosphorylated ERK2 in complex with ORF45
7OPM の概要
エントリーDOI | 10.2210/pdb7opm/pdb |
分子名称 | Mitogen-activated protein kinase 1, synthetic ERK2 inhibitor peptide, Protein ORF45, ... (6 entities in total) |
機能のキーワード | mapk, erk2, phosphorylated erk2, orf45, kaposi's sarcoma-associated herpesvirus, fxfp-motif, viral protein |
由来する生物種 | Homo sapiens (Human) 詳細 |
タンパク質・核酸の鎖数 | 3 |
化学式量合計 | 46365.17 |
構造登録者 | |
主引用文献 | Alexa, A.,Sok, P.,Gross, F.,Albert, K.,Kobori, E.,Poti, A.L.,Gogl, G.,Bento, I.,Kuang, E.,Taylor, S.S.,Zhu, F.,Ciliberto, A.,Remenyi, A. A non-catalytic herpesviral protein reconfigures ERK-RSK signaling by targeting kinase docking systems in the host. Nat Commun, 13:472-472, 2022 Cited by PubMed Abstract: The Kaposi's sarcoma associated herpesvirus protein ORF45 binds the extracellular signal-regulated kinase (ERK) and the p90 Ribosomal S6 kinase (RSK). ORF45 was shown to be a kinase activator in cells but a kinase inhibitor in vitro, and its effects on the ERK-RSK complex are unknown. Here, we demonstrate that ORF45 binds ERK and RSK using optimized linear binding motifs. The crystal structure of the ORF45-ERK2 complex shows how kinase docking motifs recognize the activated form of ERK. The crystal structure of the ORF45-RSK2 complex reveals an AGC kinase docking system, for which we provide evidence that it is functional in the host. We find that ORF45 manipulates ERK-RSK signaling by favoring the formation of a complex, in which activated kinases are better protected from phosphatases and docking motif-independent RSK substrate phosphorylation is selectively up-regulated. As such, our data suggest that ORF45 interferes with the natural design of kinase docking systems in the host. PubMed: 35078976DOI: 10.1038/s41467-022-28109-x 主引用文献が同じPDBエントリー |
実験手法 | X-RAY DIFFRACTION (2.45 Å) |
構造検証レポート
検証レポート(詳細版)をダウンロード